GHB Withdrawal: Timeline, Seizures, and Getting Help

GHB withdrawal is a medical emergency, and it starts faster than any other withdrawal syndrome you have heard of. Alcohol takes 6 to 24 hours after the last drink. GHB can begin inside 1 to 6 hours. Seizures are well documented. Delirium appeared in 53 percent of published cases in one review. People have died.

If you or someone you know uses GHB or GBL regularly and needs to stop, or loses access without warning, this is not a thing to ride out at home. That is the whole message. The rest is why.

Why the onset is so fast

GHB is a GABA-B receptor agonist. GABA is the brain’s main inhibitory neurotransmitter, and when you agonise those receptors repeatedly over days or weeks, the brain compensates by downregulating them, cutting their sensitivity and density to hold the balance.

Take the drug away and the compensation is still there, so the brain is left with no normal inhibitory tone. Neurons fire too easily and too often with nothing damping them. That is the same basic mechanism as alcohol or benzodiazepine withdrawal, with two differences that matter clinically.

The half-life. Alcohol lingers, which is why its withdrawal takes most of a day to arrive. GHB’s half-life is 30 to 60 minutes, among the shortest of any dependence-forming substance. A few hours after the last dose blood levels are near zero and the process has already started. Someone dosing every 2 to 4 hours around the clock has never given their brain a gap, so when the dosing stops the change is abrupt.

The receptor. Benzodiazepines act at GABA-A. GHB acts at GABA-B. Related systems, but not the same one. Benzos give some cross-stabilisation through general sedation without directly replacing what GHB was doing, which is why GHB withdrawal often needs benzodiazepine doses that would flatten anyone else, and why some cases barely respond at all.

The timeline

1 to 6 hours. Insomnia, anxiety, sweating and tremor. For an around-the-clock user these can start before the next dose would normally have been due.

6 to 24 hours. Autonomic instability becomes obvious: tachycardia, rising blood pressure, heavy sweating. The nervous system is losing regulation.

24 to 72 hours. Peak severity, and the most dangerous window. Autonomic instability at its worst, confusion setting in, often to the point where the person cannot say where they are.

24 to 96 hours. The delirium window: disorientation, psychosis, severe agitation, documented in 53 percent of cases in a 2004 review of the published literature. This is not “being out of it.” Sedative-hypnotic withdrawal delirium can leave people combative, self-injuring, and deteriorating fast without intervention.

Seizures are most likely in the first 24 to 48 hours but can happen anywhere in the acute phase.

5 to 15 days. Acute physical symptoms usually resolve across this window, with the exact length depending on how long and how heavily the person had been using. A case series of seven consecutive withdrawal patients documented exactly this course.

Weeks to months. Insomnia outlasts everything else, often by one to two months. That extended sleep disruption is a serious relapse risk in its own right, and it is worth planning for rather than being surprised by.

Who gets dependent

People dosing around the clock. GHB lasts 2 to 4 hours per dose, so festival and party use does not reliably produce dependence. What produces it is dosing every 2 to 4 hours through the day and night to hold the effect or to stay ahead of early withdrawal. Some people arrive there within weeks. The Dutch GHB Monitor study of 229 dependent patients entering detoxification documented that pattern directly, though dependence can develop at much lower doses given enough frequency.

GBL users. GBL is a prodrug that converts to GHB within minutes of swallowing it, so it produces identical dependence. The dangerous part is that the doses are not interchangeable: GBL runs roughly a 0.75:1 effective ratio to GHB by weight, so a smaller volume does the same job. Someone used to GBL who switches to GHB and keeps their volume, or the reverse, can overdose on the switch alone.

People who lose supply without warning. A hospital admission for something unrelated, a supplier going dry, a situation where dosing is impossible. Withdrawal can begin before anyone works out what is happening, and staff treating an injury have no way to know unless they are told.

People who plan to push through at home. The first few hours look manageable, which is the trap. The real danger sits 24 to 72 hours in, and by then a person in severe withdrawal is not in a position to judge how badly they are doing.

What treatment actually looks like

All of the treatment evidence here is case series and case reports. There are no randomised controlled trials, because running one on a severe withdrawal syndrome is neither ethical nor practical. Evidence tier: the lowest one. Hold everything below accordingly.

Benzodiazepines are first-line by analogy with alcohol withdrawal, giving general CNS sedation and reducing seizure risk through GABA-A. They do not substitute for GABA-B activity, so published cases describe patients needing many times the usual anxiolytic dose to get adequate sedation, with partial and inconsistent response. The 2004 literature review found that benzodiazepine-refractory cases responded to other sedatives, mainly pentobarbital or chloral hydrate.

Baclofen is a GABA-B agonist, acting on the same receptor system GHB does, so mechanistically it fits better than benzos. Case reports describe successful management with baclofen alone, and in severe prolonged withdrawal alongside a slow benzodiazepine taper. A separate case series found 30 to 60 mg a day useful for relapse prevention after detox. Still no trials.

Pharmaceutical GHB tapering is used in some European countries where sodium oxybate is available on prescription. A slow structured taper lets the brain recalibrate instead of falling off a cliff. This route is not available in the United States for this purpose.

ICU-level care is what severe cases need. That is not medicine failing. It reflects how physiologically intense this withdrawal is.

Home management is not an option for anyone with significant dependence. Between the speed of onset, the severity of the complications and the unpredictable response to every available treatment, self-managing this carries a real risk of death.

If you need to stop

Do not stop cold turkey without medical support. For someone dosing through the day, the seizure window opens within hours of the last dose.

Go to the emergency department, or call emergency services. Say plainly that it is GHB or GBL, how often, and roughly how much. You are not legally obliged to tell them, and telling them is the difference between the right treatment and a missed diagnosis. Withdrawal from a substance nobody has identified gets treated as something else entirely.

If you want to reduce rather than quit, that is safer than stopping abruptly, but tapering something with a 30 to 60 minute half-life is genuinely difficult and still carries risk without guidance. A physician who works in substance use medicine can structure it or arrange pharmaceutical support.

If someone collapses or seizes, call emergency services. Put them in the recovery position if they are unconscious but breathing. Do not leave them alone.

Plan for the insomnia. Weeks to months of bad sleep after the acute phase is normal, and exhaustion is one of the most common reasons people go back. Having support arranged for that stretch is part of the detox, not an afterthought.

For pharmacology, dosing and overdose signs, see the GHB guide. For combinations, see the interaction checker.

Sources

PMID 15225884 | PMID 11174231 | PMID 27923198 | PMID 30907765 | PMID 39021043 | PMID 25900349